🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 20 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/04/2024 25,25 25,50 24,91 25,11 -1,76% 2,34% 584.000
29/04/2024 25,43 25,83 25,13 25,56 +1,63% 2,73% 511.900
26/04/2024 24,61 25,23 24,22 25,15 +1,99% 4,10% 461.200
25/04/2024 25,13 25,35 24,51 24,66 -4,05% 3,34% 606.300
24/04/2024 26,92 27,61 25,59 25,70 -4,28% 7,50% 326.500
23/04/2024 26,65 27,78 26,61 26,85 +0,90% 4,39% 339.300
22/04/2024 25,84 26,99 25,71 26,61 +3,90% 4,95% 296.300
19/04/2024 25,11 25,63 24,79 25,61 +1,55% 3,33% 452.400
18/04/2024 25,34 25,76 25,17 25,22 -1,37% 2,31% 434.100
17/04/2024 26,39 26,39 25,35 25,57 -2,07% 3,94% 517.600
16/04/2024 26,30 26,40 25,93 26,11 -1,77% 1,79% 524.100
15/04/2024 27,18 27,35 26,32 26,58 -1,70% 3,79% 441.000
12/04/2024 27,52 27,57 26,66 27,04 -2,24% 3,31% 638.000
11/04/2024 28,20 28,40 27,37 27,66 -0,79% 3,67% 543.000
10/04/2024 28,22 28,54 27,74 27,88 -4,29% 2,83% 704.300
09/04/2024 28,15 29,21 27,94 29,13 +3,70% 4,52% 885.900
08/04/2024 28,06 28,11 27,43 28,09 +0,32% 2,42% 313.500
05/04/2024 27,45 28,61 26,92 28,00 +1,27% 6,16% 395.600
04/04/2024 28,42 29,00 27,55 27,65 -1,50% 5,10% 777.300
03/04/2024 27,71 28,40 27,71 28,07 +0,29% 2,49% 655.500
02/04/2024 27,74 28,11 27,59 27,99 -1,03% 1,87% 731.800
01/04/2024 28,77 28,90 27,64 28,28 -2,25% 4,36% 842.200
28/03/2024 28,42 29,27 28,13 28,93 +1,58% 4,01% 653.400
27/03/2024 28,17 28,62 27,94 28,48 +1,71% 2,41% 359.400
26/03/2024 28,42 28,42 27,59 28,00 +0,39% 2,94% 307.500
25/03/2024 28,11 28,44 27,63 27,89 -0,50% 2,90% 247.400
22/03/2024 28,37 28,42 27,83 28,03 -1,13% 2,10% 376.500
21/03/2024 29,40 29,73 28,25 28,35 -1,84% 5,03% 586.100
20/03/2024 28,65 28,94 28,02 28,88 +0,21% 3,21% 465.600
19/03/2024 28,56 28,95 28,26 28,82 +1,26% 2,42% 432.900